KORU Medical Systems (KRMD) Revenue & Earnings 2020-2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Revenue & Profit
Revenue, EBITDA, operating income, net income, EPS, and shares across quarters
TTM Revenue
$45.11M
22.4%
Q. Revenue
$12.05M
TTM EBITDA
$-861,497
78.4%
TTM Op. Income
$-1.65M
65.9%
Q. Op. Income
$626,991
TTM Net Income
$-1.82M
59.7%
Q. Net Income
$252,449
EPS
$0.01
Shares Out.
$46.08M
0.2%
$45.11M in TTM revenue grew 22.4% YoY, reaching $12.05M last quarter. TTM EBITDA of $-861,497 and TTM operating income of $-1.65M show growth is flowing through to the bottom line. However, net income is negative at $1.82M — growth is not yet reaching the bottom line.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders
